Baxter International Inc. logo BAX - Baxter International Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 15
HOLD 20
SELL 1
STRONG
SELL 0
| PRICE TARGET: $23.60 DETAILS
HIGH: $28.00
LOW: $20.00
MEDIAN: $24.00
CONSENSUS: $23.60
DOWNSIDE: 5.18%

Stock News

Baxter International: The Vantive Transition Complicates Margin Recovery

Baxter International: The Vantive Transition Complicates Margin Recovery

Baxter International is rated Hold, with a $25 target price and limited 2.6% upside, reflecting muted near-term margin recovery. Revenue growth is supported by Advanced Surgery and compounding, but infusion solutions face structural headwinds, and Novum IQ LVP supply issues persist. Margins lag revenue growth; cost reductions and inventory normalization may help, but transition expenses and debt reduction remain priorities through 2027.

Oct 13, 2026 03:10 AM • seekingalpha.com
Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL)

Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL)

Omnicell (NASDAQ: OMCL - Get Free Report) and Baxter International (NYSE: BAX - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings. Analyst Recommendations This is a breakdown of recent ratings

Oct 10, 2026 10:58 PM • defenseworld.net
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/analyst/129835310?pwd=2FG2j7ZZ to pre-register for the call and receive the call information.This call is also being webcast and can be accessed through Baxter's website at www.

Oct 07, 2026 12:15 PM • businesswire.com
Baxter Releases Inaugural Connected Hospital Report

Baxter Releases Inaugural Connected Hospital Report

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes. Based on a survey of 150 information technology (IT) and nursing leaders, the report examines how hospitals are progressing along a “connected hospital” journey by identifying four distin.

Sep 30, 2026 05:00 AM • businesswire.com
TELA Bio (NASDAQ:TELA) versus Baxter International (NYSE:BAX) Head to Head Analysis

TELA Bio (NASDAQ:TELA) versus Baxter International (NYSE:BAX) Head to Head Analysis

Baxter International (NYSE: BAX - Get Free Report) and TELA Bio (NASDAQ: TELA - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Volatility and Risk Baxter International has a beta

Sep 09, 2026 11:45 PM • defenseworld.net
Baxter Appoints John Rogers Chief Financial Officer

Baxter Appoints John Rogers Chief Financial Officer

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives,” said Hider. “He is an ideal fit for.

Aug 19, 2026 04:00 AM • businesswire.com
Baxter Announces Pricing for Its Upsized Cash Tender Offers

Baxter Announces Pricing for Its Upsized Cash Tender Offers

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the “Accep.

Aug 18, 2026 12:56 PM • businesswire.com
Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers

Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early results of its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), whi.

Aug 18, 2026 05:00 AM • businesswire.com

Price Targets